Over the past year there were no insider purchases at Vanda Pharmaceuticals Inc.. Six insiders sold roughly $2.8 million instead.
That's worth context: executives sell for plenty of routine reasons, from scheduled trading plans to tax bills. Buying is the rarer, more telling signal.
No open-market insider buying or selling in the last full quarter. Insiders bought in 3 of the last 7 full quarters. Big money check: 172 institutions held VNDA as of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Williams Timothy | Executive Officer | Sell | 42,434 | $8.27 | $351K | SEC |
| Mar 4, 2026 | Moran Kevin Patrick | CFO | Sell | 42,442 | $8.27 | $351K | SEC |
| Mar 4, 2026 | Wijkstrom Joakim | Executive Officer | Sell | 30,800 | $8.27 | $255K | SEC |
| Mar 4, 2026 | Polymeropoulos Mihael Hristos | CEO | Sell | 156,235 | $8.17 | $1.3M | SEC |
| Mar 4, 2026 | Birznieks Gunther | Executive Officer | Sell | 42,431 | $8.27 | $351K | SEC |
| Feb 24, 2026 | Honore Tage | Director | Sell | 30,000 | $8.03 | $241K | SEC |
| Aug 8, 2025 | Polymeropoulos Mihael Hristos | CEO | Buy | 10,000 | $4.15 | $42K | SEC |
| Jun 16, 2025 | Mitchell Stephen Ray | Director | Sell | 7,000 | $4.59 | $32K | SEC |
| May 21, 2025 | Polymeropoulos Mihael Hristos | CEO | Buy | 9,519 | $4.40 | $42K | SEC |
| May 21, 2025 | Polymeropoulos Mihael Hristos | CEO | Buy | 481 | $4.39 | $2K | SEC |
| May 19, 2025 | Polymeropoulos Mihael Hristos | CEO | Buy | 20,000 | $4.22 | $84K | SEC |
| Mar 6, 2025 | Polymeropoulos Mihael Hristos | CEO | Buy | 5,000 | $5.01 | $25K | SEC |
| Mar 6, 2025 | Polymeropoulos Mihael Hristos | CEO | Buy | 5,000 | $5.02 | $25K | SEC |
| Mar 5, 2025 | Polymeropoulos Mihael Hristos | CEO | Buy | 5,000 | $5.01 | $25K | SEC |
| Mar 5, 2025 | Polymeropoulos Mihael Hristos | CEO | Buy | 5,000 | $5.03 | $25K | SEC |
In the last 12 months Vanda Pharmaceuticals Inc. insiders made open-market purchases worth about $0 and sales worth about $2.8 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in VNDA was filed on 2026-03-04.
172 investment managers reported holding VNDA in SEC Form 13F filings for Q2 2026.
No congressional trades in VNDA were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).